CRYO CELL INTERNATIONAL INC (CCEL)
Cryo-Cell International, Inc. engages in cord blood and cord tissue cryopreservation services in the United States. The company offers cellular processing and cryogenic storage for family use, primarily for collection and preservation of umbilical cord blood, and tissue stem cells; and cellular processing and cryogenic storage of umbilical cord blood stem cells for public use. It is also involved in the manufacturing of PrepaCyte CB processing system units for processing umbilical cord blood stem cells. In addition, the company provides cold storage services to third-party pharmaceutical companies and medical institutions. It markets its cord blood stem cell preservation services directly to expectant parents, as well as by distributing information through obstetricians, pediatricians, childbirth educators, certified nurse-midwives, and other related healthcare professionals. The company was incorporated in 1989 and is headquartered in Oldsmar, Florida.
Sector: Services-Misc Health & Allied Services, NEC
Industry: Medical - Care Facilities
Cryo-Cell International, Inc.
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
based on 8.06M shares outstanding
USCryo-Cell International, Inc. engages in cord blood and cord tissue cryopreservation services in the United States.
The company offers cellular processing and cryogenic storage for family use, primarily for collection and preservation of umbilical cord blood, and tissue stem cells; and cellular processing and cryogenic storage of umbilical cord blood stem cells for public use.
It is also involved in the manufacturing of PrepaCyte CB processing system units for processing umbilical cord blood stem cells.
In addition, the company provides cold storage services to third-party pharmaceutical companies and medical institutions.
It markets its cord blood stem cell preservation services directly to expectant parents, as well as by distributing information through obstetricians, pediatricians, childbirth educators, certified nurse-midwives, and other related healthcare professionals.
The company was incorporated in 1989 and is headquartered in Oldsmar, Florida.
Leadership
David I. Portnoy
Chairman & Co-CEO
Mark L. Portnoy
Co-CEO & Director
Oleg Mikulinsky
Chief Information Officer
Jill Taymans
Chief Financial Officer & Vice President of Finance
Employees
73
Country
US
Sector
Healthcare
Website
cryo-cell.com
| Insider | Title | Type | Shares | Value | Date |
|---|---|---|---|---|---|
 PORTNOY DAVID | Chairman, Co-CEO | Other | 600.2K | $800.0K | Aug 5, 2026 |
| PORTNOY DAVID | Chairman, Co-CEO | Other | 600.2K | $800.0K | Aug 5, 2026 |
 TAYMANS JILL M | VP Finance, CFO | Option Exercise | 7.5K | $23.3K | May 28, 2026 |
| TAYMANS JILL M | VP Finance, CFO | Option Exercise | 7.5K | $23.3K | May 28, 2026 |
 Mikulinsky Oleg | Chief Information Officer | Grant/Award | 10.0K | $35.4K | Jan 7, 2026 |
| TAYMANS JILL M | VP Finance, CFO | Grant/Award | 20.0K | $70.8K | Jan 7, 2026 |
| Name | Shares | % | Source |
|---|---|---|---|
Camac Fund, LP · joint filing· may incl. warrants· filed Jul 2026 | 551.1K | 6.8% | 13D |
 PORTNOY DAVID Chairman, Co-CEO, Director, 10% Owner | 247.4K | 3.1% | FORM 4 |
SFI Advisors, LLC | 165.3K | 2.1% | 13F |
VANGUARD CAPITAL MANAGEMENT LLC | 165.0K | 2.0% | 13F |
MassMutual Private Wealth & Trust, FSB | 111.0K | 1.4% | 13F |
 Mikulinsky Oleg Chief Information Officer | 104.3K | 1.3% | FORM 4 |
 Berger Harold D. Director | 57.9K | 0.7% | FORM 4 |
 TAYMANS JILL M VP Finance, CFO | 52.9K | 0.7% | FORM 4 |
GEODE CAPITAL MANAGEMENT, LLC | 46.3K | 0.6% | 13F |
 Mizrahi Daniel Director | 30.6K | 0.4% | FORM 4 |
Insiders
- PORTNOY DAVIDChairman, Co-CEO
- TAYMANS JILL MVP Finance, CFO
- Mikulinsky OlegChief Information Officer
- Portnoy Mark L.Co-CEO
- Berger Harold D.Director
- Mizrahi DanielDirector
based on 8.06M shares outstanding
US30d Avg
13.22K
60d Avg
13.50K
90d Avg
25.00K